Epithelium: The interplay between innate and Th2 immunity

Immunology and Cell Biology

Volumn 88, Issue 3, 2010, Pages 257-268

  Bulek, Katarzyna ^a   Swaidani, Shadi ^a,b   Aronica, Mark ^a   Li, Xiaoxia ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 25; INTERLEUKIN 3; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; MESSENGER RNA; REGULATOR PROTEIN; STAT6 PROTEIN; T LYMPHOCYTE RECEPTOR; THYMIC STROMAL LYMPHOPOIETIN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR NFAT;

ADAPTIVE IMMUNITY; ALLERGY; BACTERIUM DETECTION; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL POLARITY; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; EOSINOPHIL; EPITHELIUM; EPITHELIUM CELL; GENE EXPRESSION; HELPER CELL; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; INFLAMMATORY CELL; INNATE IMMUNITY; MICROFLORA; MOLECULAR MECHANICS; NATURAL KILLER T CELL; NONHUMAN; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; TH2 CELL;

ANIMALS; CYTOKINES; EPITHELIUM; HUMANS; HYPERSENSITIVITY; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; INFLAMMATION; INTERLEUKIN-17; INTERLEUKINS; TH2 CELLS;

EID: 77949875637     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2009.113     Document Type: Review

References (172)

1. Medzhitov R, Janeway Jr CA. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997; 91: 295-298.
2. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2: 675-680.
3. Benko S, Philpott DJ, Girardin SE. The microbial and danger signals that activate nodlike receptors. Cytokine 2008; 43: 368-373.
4. Shaw MH, Reimer T, Kim YG, Nunez G. NOD-like receptors (NLRs): bona fide intracellular microbial sensors. Curr Opin Immunol 2008; 20: 377-382.
5. Dong C, Flavell RA. Th1 and Th2 cells. Curr Opin Hematol 2001; 8: 47-51.
6. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-173.
7. Dong C. Differentiation and function of pro-inflammatory Th17 cells. Microbes Infect 2009; 11: 584-588.
8. Holgate ST. The airway epithelium is central to the pathogenesis of asthma. Allergol Int 2008; 57: 1-10.
9. Saenz SA, Taylor BC, Artis D. Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol Rev 2008; 226: 172-190.
10. Sansonetti PJ. War and peace at mucosal surfaces. Nat Rev Immunol 2004; 4: 953-964.
11. Schleimer RP, Kato A, Kern R, Kuperman D, Avila PC. Epithelium: at the interface of innate and adaptive immune responses. J Allergy Clin Immunol 2007; 120: 1279-1284.
12. Hammad H, Lambrecht BN. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol 2008; 8: 193-204.
13. Liu YJ, Soumelis V, Watanabe N, Ito T, Wang YH, Malefyt Rde W et al. TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol 2007; 25: 193-219.
14. Berg RD. The indigenous gastrointestinal microflora. Trends Microbiol 1996; 4: 430-435.
15. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001; 292: 1115-1118.
16. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001; 291: 881-884.
17. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417-429.
18. Chuang TH, Ulevitch RJ. Cloning and characterization of a sub-family of human tolllike receptors: hTLR7, hTLR8 and hTLR9. Eur Cytokine Netw 2000; 11: 372-378.
19. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H et al. A toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740-745.
20. Medzhitov R, Preston-Hurlburt P, Janeway Jr CA. A human homologue of the Drosophila toll protein signals activation of adaptive immunity. Nature 1997; 388: 394-397.
21. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. A family of human receptors structurally related to Drosophila toll. Proc Natl Acad Sci USA 1998; 95: 588-593.
22. Takeuchi O, Kawai T, Sanjo H, Copeland NG, Gilbert DJ, Jenkins NA et al. TLR6: a novel member of an expanding toll-like receptor family. Gene 1999; 231: 59-65.
23. Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004; 303: 1522-1526.
24. Abreu MT, Thomas LS, Arnold ET, Lukasek K, Michelsen KS, Arditi M. TLR signaling at the intestinal epithelial interface. J Endotoxin Res 2003; 9: 322-330.
25. Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J Immunol 2005; 174: 4453-4460.
26. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229-241.
27. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118: 285-296.
28. Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005; 5: 749-759.
29. Garlanda C, Riva F, Polentarutti N, Buracchi C, Sironi M, De Bortoli M et al. Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. Proc Natl Acad Sci USA 2004; 101: 3522-3526.
30. Wald D, Qin J, Zhao Z, Qian Y, Naramura M, Tian L et al. SIGIRR, a negative regulator of toll-like receptor-interleukin 1 receptor signaling. Nat Immunol 2003; 4: 920-927.
31. Qin J, Qian Y, Yao J, Grace C, Li X. SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms. J Biol Chem 2005; 280: 25233-25241.
32. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008; 8: 411-420.
33. Coombes JL, Powrie F. Dendritic cells in intestinal immune regulation. Nat Rev Immunol 2008; 8: 435-446.
34. Strober W. The multifaceted influence of the mucosal microflora on mucosal dendritic cell responses. Immunity 2009; 31: 377-388.
35. Barnes MJ, Powrie F. Regulatory T cells reinforce intestinal homeostasis. Immunity 2009; 31: 401-411.
36. Lloyd CM, Hawrylowicz CM. Regulatory T cells in asthma. Immunity 2009; 31: 438-449.
37. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003; 278: 8869-8872.
38. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nuñ ez G et al. Nod2- dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005; 307: 731-734.
39. Chamaillard M, Hashimoto M, Horie Y, Masumoto J, Qiu S, Saab L et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 2003; 4: 702-707.
40. Chaouche-Drider N, Kaparakis M, Karrar A, Fernandez MI, Carneiro LA, Viala J et al. A commensal Helicobacter sp. of the rodent intestinal flora activates TLR2 and NOD1 responses in epithelial cells. PLoS One 2009; 4: e5396.
41. Fritz JH, Le Bourhis L, Sellge G, Magalhaes JG, Fsihi H, Kufer TA et al. Nod1- mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 2007; 26: 445-459.
42. Girardin SE, Boneca IG, Carneiro LA, Antignac A, Jéhanno M, Viala J et al. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 2003; 300: 1584-1587.
43. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004; 5: 1166-1174.
44. Zaph C, Troy AE, Taylor BC, Berman-Booty LD, Guild KJ, Du Y et al. Epithelial-cellintrinsic IKK-beta expression regulates intestinal immune homeostasis. Nature 2007; 446: 552-556.
45. Herrick CA, Bottomly K. To respond or not to respond: T cells in allergic asthma. Nat Rev Immunol 2003; 3: 405-412.
46. Kay AB, Phipps S, Robinson DS. A role for eosinophils in airway remodelling in asthma. Trends Immunol 2004; 25: 477-482.
47. Larche M, Robinson DS, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 2003; 111: 450-463.
48. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999; 17: 255-281.
49. Kay AB. The role of T lymphocytes in asthma. Chem Immunol Allergy 2006; 91: 59-75.
50. Lan RS, Stewart GA, Henry PJ. Role of protease-activated receptors in airway function: a target for therapeutic intervention? Pharmacol Ther 2002; 95: 239-257.
51. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R. Proteinase-activated receptors. Pharmacol Rev 2001; 53: 245-282.
52. Ebeling C, Forsythe P, Ng J, Gordon JR, Hollenberg M, Vliagoftis H. Proteinaseactivated receptor 2 activation in the airways enhances antigen-mediated airway inflammation and airway hyperresponsiveness through different pathways. J Allergy Clin Immunol 2005; 115: 623-630.
53. Takizawa T, Tamiya M, Hara T, Matsumoto J, Saito N, Kanke T et al. Abrogation of bronchial eosinophilic inflammation and attenuated eotaxin content in proteaseactivated receptor 2-deficient mice. J Pharmacol Sci 2005; 98: 99-102.
54. Asokananthan N, Graham PT, Stewart DJ, Bakker AJ, Eidne KA, Thompson PJ et al. House dust mite allergens induce proinflammatory cytokines from respiratory epithelial cells: the cysteine protease allergen, Der p 1, activates protease-activated receptor (PAR)-2 and inactivates PAR-1. J Immunol 2002; 169: 4572-4578.
55. Liu AH. Endotoxin exposure in allergy and asthma: reconciling a paradox. J Allergy Clin Immunol 2002; 109: 379-392.
56. Schwartz DA. Does inhalation of endotoxin cause asthma? AmJ Respir Crit Care Med 2001; 163: 305-306.
57. Trompette A, Divanovic S, Visintin A, Blanchard C, Hegde RS, Madan R et al. Allergenicity resulting from functional mimicry of a toll-like receptor complex protein. Nature 2009; 457: 585-588.
58. Holtzman MJ, Byers DE, Benoit LA, Battaile JT, You Y, Agapov E et al. Immune pathways for translating viral infection into chronic airway disease. Adv Immunol 2009; 102: 245-276.
59. Dabbagh K, Lewis DB. Toll-like receptors and T-helper-1/T-helper-2 responses. Curr Opin Infect Dis 2003; 16: 199-204.
60. Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K. Lipopolysaccharide- enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002; 196: 1645-1651.
61. Gaffen SL. An overview of IL-17 function and signaling. Cytokine 2008; 43: 402-407.
62. Kawaguchi M, Onuchic LF, Li XD, Essayan DM, Schroeder J, Xiao HQ et al. Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J Immunol 2001; 167: 4430-4435.
63. Shen F, Gaffen SL. Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine 2008; 41: 92-104.
64. Wright JF, Bennett F, Li B, Brooks J, Luxenberg DP, Whitters MJ et al. The human IL- 17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. J Immunol 2008; 181: 2799-2805.
65. Yang XO, Chang SH, Park H, Nurieva R, Shah B, Acero L et al. Regulation of inflammatory responses by IL-17F. J Exp Med 2008; 205: 1063-1075.
66. Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest 2006; 116: 1218-1222.
67. Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002; 17: 375-387.
68. Moseley TA, Haudenschild DR, Rose L, Reddi AH. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003; 14: 155-174.
69. Goswami S, Angkasekwinai P, Shan M, Greenlee KJ, Barranco WT, Polikepahad S et al. Divergent functions for airway epithelial matrix metalloproteinase 7 and retinoic acid in experimental asthma. Nat Immunol 2009; 10: 496-503.
70. Lee J, Ho WH, Maruoka M, Corpuz RT, Baldwin DT, Foster JS et al. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J Biol Chem2001; 276: 1660-1664.
71. Zaph C, Du Y, Saenz SA, Nair MG, Perrigoue JG, Taylor BC et al. Commensaldependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine. J Exp Med 2008; 205: 2191-2198.
72. Hurst SD, Muchamuel T, Gorman DM, Gilbert JM, Clifford T, Kwan S et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 2002; 169: 443-453.
73. Tamachi T, Maezawa Y, Ikeda K, Kagami S, Hatano M, Seto Y et al. IL-25 enhances allergic airway inflammation by amplifying a TH2 cell-dependent pathway in mice. J Allergy Clin Immunol 2006; 118: 606-614.
74. Angkasekwinai P, Park H, Wang YH, Wang YH, Chang SH, Corry DB et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 2007; 204: 1509-1517.
75. Wang YH, Angkasekwinai P, Lu N, Voo KS, Arima K, Hanabuchi S et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 2007; 204: 1837-1847.
76. Ikeda K, Nakajima H, Suzuki K, Kagami S, Hirose K, Suto A et al. Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation. Blood 2003; 101: 3594-3596.
77. Kang CM, Jang AS, Ahn MH, Shin JA, Kim JH, Choi YS et al. Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles. Am J Respir Cell Mol Biol 2005; 33: 290-296.
78. Toy D, Kugler D, Wolfson M, Vanden Bos T, Gurgel J, Derry J et al. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J Immunol 2006; 177: 36-39.
79. Trajkovic V, Stosic-Grujicic S, Samardzic T, Markovic M, Miljkovic D, Ramic Z et al. Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes. J Neuroimmunol 2001; 119: 183-191.
80. Maezawa Y, Nakajima H, Suzuki K, Tamachi T, Ikeda K, Inoue J et al. Involvement of TNF receptor-associated factor 6 in IL-25 receptor signaling. J Immunol 2006; 176: 1013-1018.
81. Wong CK, Cheung PF, Ip WK, Lam CW. Interleukin-25-induced chemokines and interleukin-6 release from eosinophils is mediated by p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, and nuclear factor-kappaB. Am J Respir Cell Mol Biol 2005; 33: 186-194.
82. Rickel EA, Siegel LA, Yoon BR, Rottman JB, Kugler DG, Swart DA et al. Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J Immunol 2008; 181: 4299-4310.
83. Novatchkova M, Leibbrandt A, Werzowa J, Neubuser A, Eisenhaber F. The STIRdomain superfamily in signal transduction, development and immunity. Trends Biochem Sci 2003; 28: 226-229.
84. Claudio E, Sonder SU, Saret S, Carvalho G, Ramalingam TR, Wynn TA et al. The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation. J Immunol 2009; 182: 1617-1630.
85. Qian Y, Liu C, Hartupee J, Altuntas CZ, Gulen MF, Jane-Wit D et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 2007; 8: 247-256.
86. Swaidani S, Bulek K, Kang Z, Liu C, Lu Y, Yin W et al. The critical role of epithelialderived Act1 in IL-17- and IL-25-mediated pulmonary inflammation. J Immunol 2009; 182: 1631-1640.
87. Liu C, Qian W, Qian Y, Giltiay NV, Lu Y, Swaidani S et al. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Sci Signal 2009; 2: ra63.
88. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23: 479-490.
89. Luthi AU, Cullen SP, McNeela EA, Duriez PJ, Afonina IS, Sheridan C et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009; 31: 84-98.
90. Cayrol C, Girard JP. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci USA 2009; 106: 9021-9026.
91. Talabot-Ayer D, Lamacchia C, Gabay C, Palmer G. Interleukin-33 is biologically active independently of caspase-1 cleavage. J Biol Chem 2009; 284: 19420-19426.
92. Humphreys NE, Xu D, Hepworth MR, Liew FY, Grencis RK. IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J Immunol 2008; 180: 2443-2449.
93. Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L et al. IL-33, the IL- 1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci USA 2007; 104: 282-287.
94. Hudson CA, Christophi GP, Gruber RC, Wilmore JR, Lawrence DA, Massa PT. Induction of IL-33 expression and activity in central nervous system glia. J Leukoc Biol 2008; 84: 631-643.
95. Kuchler AM, Pollheimer J, Balogh J, Sponheim J, Manley L, Sorensen DR et al. Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation. Am J Pathol 2008; 173: 1229-1242.
96. Moussion C, Ortega N, Girard JP. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One 2008; 3: e3331.
97. Wood IS, Wang B, Trayhurn P. IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes. Biochem Biophys Res Commun 2009; 384: 105-109.
98. Chackerian AA, Oldham ER, Murphy EE, Schmitz J, Pflanz S, Kastelein RA. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol 2007; 179: 2551-2555.
99. Palmer G, Lipsky BP, Smithgall MD, Meininger D, Siu S, Talabot-Ayer D et al. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. Cytokine 2008; 42: 358-364.
100. Ho LH, Ohno T, Oboki K, Kajiwara N, Suto H, Iikura M et al. IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals. J Leukoc Biol 2007; 82: 1481-1490.
101. Bulek K, Swaidani S, Qin J, Lu Y, Gulen MF, Herjan T et al. The essential role of single Ig IL-1 receptor-related molecule/toll IL-1R8 in regulation of Th2 immune response. J Immunol 2009; 182: 2601-2609.
102. Hayakawa H, Hayakawa M, Kume A, Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 2007; 282: 26369-26380.
103. Miller AM, Xu D, Asquith DL, Denby L, Li Y, Sattar N et al. IL-33 reduces the development of atherosclerosis. J Exp Med 2008; 205: 339-346.
104. Friend SL, Hosier S, Nelson A, Foxworthe D, Williams DE, Farr A. A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells. Exp Hematol 1994; 22: 321-328.
105. Sims JE, Williams DE, Morrissey PJ, Garka K, Foxworthe D, Price V et al. Molecular cloning and biological characterization of a novel murine lymphoid growth factor. J Exp Med 2000; 192: 671-680.
106. Leonard WJ. TSLP: finally in the limelight. Nat Immunol 2002; 3: 605-607.
107. Al Shami A, Spolski R, Kelly J, Keane-Myers A, Leonard WJ. A role for TSLP in the development of inflammation in an asthma model. J Exp Med 2005; 202: 829-839.
108. Zhou B, Comeau MR, De Smedt T, Liggitt HD, Dahl ME, Lewis DB et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol 2005; 6: 1047-1053.
109. Ying S, O'Connor B, Ratoff J, Meng Q, Mallett K, Cousins D et al. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol 2005; 174: 8183-8190.
110. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002; 3: 673-680.
111. Rimoldi M, Chieppa M, Salucci V, Avogadri F, Sonzogni A, Sampietro GM et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 2005; 6: 507-514.
112. Tanaka J, Watanabe N, Kido M, Saga K, Akamatsu T, Nishio A et al. Human TSLP and TLR3 ligands promote differentiation of Th17 cells with a central memory phenotype under Th2-polarizing conditions. Clin Exp Allergy 2009; 39: 89-100.
113. Watanabe N, Hanabuchi S, Soumelis V, Yuan W, Ho S, de Waal Malefyt R et al. Human thymic stromal lymphopoietin promotes dendritic cell-mediated CD4+ T cell homeostatic expansion. Nat Immunol 2004; 5: 426-434.
114. Kato A, Favoreto Jr S, Avila PC, Schleimer RP. TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J Immunol 2007; 179: 1080-1087.
115. Miyata M, Nakamura Y, Shimokawa N, Ohnuma Y, Katoh R, Matsuoka S et al. TSLP is a critical mediator of IL-13-driven allergic inflammation. Eur J Immunol 2009; 39: 3078-3083.
116. Allakhverdi Z, Comeau MR, Jessup HK, Yoon BR, Brewer A, Chartier S et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 2007; 204: 253-258.
117. Bogiatzi SI, Fernandez I, Bichet JC, Marloie-Provost MA, Volpe E, Sastre X et al. Cutting edge: proinflammatory and Th2 cytokines synergize to induce thymic stromal lymphopoietin production by human skin keratinocytes. J Immunol 2007; 178: 3373-3377.
118. Lee HC, Ziegler SF. Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFkappaB. Proc Natl Acad Sci USA 2007; 104: 914-919.
119. Miyata M, Hatsushika K, Ando T, Shimokawa N, Ohnuma Y, Katoh R et al. Mast cell regulation of epithelial TSLP expression plays an important role in the development of allergic rhinitis. Eur J Immunol 2008; 38: 1487-1492.
120. Li M, Hener P, Zhang Z, Kato S, Metzger D, Chambon P. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci USA 2006; 103: 11736-11741.
121. Li M, Messaddeq N, Teletin M, Pasquali JL, Metzger D, Chambon P. Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin. Proc Natl Acad Sci USA 2005; 102: 14795-14800.
122. Kouzaki H, O'Grady SM, Lawrence CB, Kita H. Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2. J Immunol 2009; 183: 1427-1434.
123. Reche PA, Soumelis V, Gorman DM, Clifford T, Liu Mr, Travis M et al. Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J Immunol 2001; 167: 336-343.
124. Sokol CL, Barton GM, Farr AG, Medzhitov R. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol 2008; 9: 310-318.
125. Pandey A, Ozaki K, Baumann H, Levin SD, Puel A, Farr AG et al. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat Immunol 2000; 1: 59-64.
126. Park LS, Martin U, Garka K, Gliniak B, Di Santo JP, Muller W et al. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: formation of a functional heteromeric complex requires interleukin 7 receptor. J Exp Med 2000; 192: 659-670.
127. Isaksen DE, Baumann H, Trobridge PA, Farr AG, Levin SD, Ziegler SF. Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction. J Immunol 1999; 163: 5971-5977.
128. Levin SD, Koelling RM, Friend SL, Isaksen DE, Ziegler SF, Perlmutter RM et al. Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism. J Immunol 1999; 162: 677-683.
129. Iwasaki A, Kelsall BL. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J Exp Med 1999; 190: 229-239.
130. Iwasaki A, Kelsall BL. Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer's patch dendritic cells. J Immunol 2001; 166: 4884-4890.
131. Annacker O, Coombes JL, Malmstrom V, Uhlig HH, Bourne T, Johansson-Lindbom B et al. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J Exp Med 2005; 202: 1051-1061.
132. Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM, Belkaid Y et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J ExpMed 2007; 204: 1757-1764.
133. Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007; 204: 1775-1785.
134. Watanabe N, Wang YH, Lee HK, Ito T, Wang YH, Cao W et al. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 2005; 436: 1181-1185.
135. Lee JY, Lim YM, Park MJ, Min SY, Cho ML, Sung YC et al. Murine thymic stromal lymphopoietin promotes the differentiation of regulatory T cells from thymic CD4(+)CD8(-)CD25(-) naive cells in a dendritic cell-independent manner. Immunol Cell Biol 2008; 86: 206-213.
136. Ballantyne SJ, Barlow JL, Jolin HE, Nath P, Williams AS, Chung KF et al. Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J Allergy Clin Immunol 2007; 120: 1324-1331.
137. Cheung PF, Wong CK, Ip WK, Lam CW. IL-25 regulates the expression of adhesion molecules on eosinophils: mechanism of eosinophilia in allergic inflammation. Allergy 2006; 61: 878-885.
138. Fallon PG, Ballantyne SJ, Mangan NE, Barlow JL, Dasvarma A, Hewett DR et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med 2006; 203: 1105-1116.
139. Owyang AM, Zaph C, Wilson EH, Guild KJ, McClanahan T, Miller HR et al. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J Exp Med 2006; 203: 843-849.
140. Taylor BC, Zaph C, Troy AE, Du Y, Guild KJ, Comeau MR et al. TSLP regulates intestinal immunity and inflammation in mouse models of helminth infection and colitis. J Exp Med 2009; 206: 655-667.
141. Massacand JC, Stettler RC, Meier R, Humphreys NE, Grencis RK, Marsland BJ et al. Helminth products bypass the need for TSLP in Th2 immune responses by directly modulating dendritic cell function. Proc Natl Acad Sci USA 2009; 106: 13968-13973.
142. Ramalingam TR, Pesce JT, Mentink-Kane MM, Madala S, Cheever AW, Comeau MR et al. Regulation of helminth-induced Th2 responses by thymic stromal lymphopoietin. J Immunol 2009; 182: 6452-6459.
143. Townsend MJ, Fallon PG, Matthews DJ, Jolin HE, McKenzie AN. T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J Exp Med 2000; 191: 1069-1076.
144. Sharkhuu T, Matthaei KI, Forbes E, Mahalingam S, Hogan SP, Hansbro PM et al. Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity. Clin Exp Allergy 2006; 36: 1575-1583.
145. Liu X, Li M, Wu Y, Zhou Y, Zeng L, Huang T. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochem Biophys Res Commun 2009; 386: 181-185.
146. Coyle AJ, Lloyd C, Tian J, Nguyen T, Erikkson C, Wang L et al. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med 1999; 190: 895-902.
147. Lohning M, Stroehmann A, Coyle AJ, Grogan JL, Lin S, Gutierrez-Ramos JC et al. T1/ ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci USA 1998; 95: 6930-6935.
148. Meisel C, Bonhagen K, Lohning M, Coyle AJ, Gutierrez-Ramos JC, Radbruch A et al. Regulation and function of T1/ST2 expression on CD4+ T cells: induction of type 2 cytokine production by T1/ST2 cross-linking. J Immunol 2001; 166: 3143-3150.
149. Kurowska-Stolarska M, Kewin P, Murphy G, Russo RC, Stolarski B, Garcia CC et al. IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J Immunol 2008; 181: 4780-4790.
150. Kondo Y, Yoshimoto T, Yasuda K, Futatsugi-Yumikura S, Morimoto M, Hayashi N et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int Immunol 2008; 20: 791-800.
151. Smithgall MD, Comeau MR, Yoon BR, Kaufman D, Armitage R, Smith DE. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol 2008; 20: 1019-1030.
152. Yoo J, Omori M, Gyarmati D, Zhou B, Aye T, Brewer A et al. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med 2005; 202: 541-549.
153. Ito T, Wang YH, Duramad O, Hori T, Delespesse GJ, Watanabe N et al. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 2005; 202: 1213-1223.
154. Seshasayee D, Lee WP, Zhou M, Shu J, Suto E, Zhang J et al. In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation. J Clin Invest 2007; 117: 3868-3878.
155. Gilliet M, Soumelis V, Watanabe N, Hanabuchi S, Antonenko S, de Waal-Malefyt R et al. Human dendritic cells activated by TSLP and CD40L induce proallergic cytotoxic T cells. J Exp Med 2003; 197: 1059-1063.
156. Nakayama T, Yamashita M. Initiation and maintenance of Th2 cell identity. Curr Opin Immunol 2008; 20: 265-271.
157. Zhu J, Min B, Hu-Li J, Watson CJ, Grinberg A, Wang Q et al. Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat Immunol 2004; 5: 1157-1165.
158. Zhu J, Paul WE. CD4T cells: fates, functions, and faults. Blood 2008; 112: 1557-1569.
159. Komai-Koma M, Xu D, Li Y, McKenzie AN, McInnes IB, Liew FY. IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol 2007; 37: 2779-2786.
160. Matsuda JL, Mallevaey T, Scott-Browne J, Gapin L. CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system. Curr Opin Immunol 2008; 20: 358-368.
161. Speak AO, Cerundolo V, Platt FM. CD1d presentation of glycolipids. Immunol Cell Biol 2008; 86: 588-597.
162. Stock P, Lombardi V, Kohlrautz V, Akbari O. Induction of airway hyperreactivity by IL-25 is dependent on a subset of invariant NKT cells expressing IL-17RB. J Immunol 2009; 182: 5116-5122.
163. Bourgeois E, Van LP, Samson M, Diem S, Barra A, Roga S et al. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur J Immunol 2009; 39: 1046-1055.
164. Nagata Y, Kamijuku H, Taniguchi M, Ziegler S, Seino K. Differential role of thymic stromal lymphopoietin in the induction of airway hyperreactivity and Th2 immune response in antigen-induced asthma with respect to natural killer T cell function. Int Arch Allergy Immunol 2007; 144: 305-314.
165. Cherry WB, Yoon J, Bartemes KR, Iijima K, Kita H. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol 2008; 121: 1484-1490.
166. Pecaric-Petkovic T, Didichenko SA, Kaempfer S, Spiegl N, Dahinden CA. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 2009; 113: 1526-1534.
167. Suzukawa M, Koketsu R, Iikura M, Nakae S, Matsumoto K, Nagase H et al. Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils. Lab Invest 2008; 88: 1245-1253.
168. Allakhverdi Z, Smith DE, Comeau MR, Delespesse G. Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 2007; 179: 2051-2054.
169. Iikura M, Suto H, Kajiwara N, Oboki K, Ohno T, Okayama Y et al. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest 2007; 87: 971-978.
170. Moulin D, Donze O, Talabot-Ayer D, Mezin F, Palmer G, Gabay C. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 2007; 40: 216-225.
171. Kroeger KM, Sullivan BM, Locksley RM. IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38\{alpha\}-de. J Leukoc Biol 2009; 86: 769-778.
172. Schneider E, Petit-Bertron AF, Bricard R, Levasseur M, Ramadan A, Girard JP et al. IL-33 activates unprimed murine basophils directly in vitro and induces their in vivo expansion indirectly by promoting hematopoietic growth factor production. J Immunol 2009; 183: 3591-3597.